| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-06 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0004 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0009 |